{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:09:10Z","timestamp":1772611750542,"version":"3.50.1"},"publisher-location":"Cham","reference-count":65,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030926151","type":"print"},{"value":"9783030926168","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-92616-8_16","type":"book-chapter","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:02:41Z","timestamp":1647241361000},"page":"397-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Immunogenetics of Non-melanoma Skin Cancer"],"prefix":"10.1007","author":[{"given":"Sabha","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"16_CR1","first-page":"120","volume":"810","author":"U Leiter","year":"2014","unstructured":"Leiter U, Eigentler T, Garbe C (2014) Epidemiology of skin cancer. Adv Exp Med Biol 810:120\u2013140","journal-title":"Adv Exp Med Biol"},{"key":"16_CR2","first-page":"62","volume":"16","author":"LL Griffin","year":"2016","unstructured":"Griffin LL, Ali FR, Lear JT (2016) Non-Melanoma Skin Cancer. Clin Med (lond) 16:62\u201365","journal-title":"Non-Melanoma Skin Cancer. Clin Med (lond)"},{"key":"16_CR3","doi-asserted-by":"crossref","unstructured":"Didona D, Paolino G, Bottoni U, Cantisani C (2018) Non Melanoma Skin Cancer Pathogenesis Overview. Biomedicines 6.","DOI":"10.3390\/biomedicines6010006"},{"key":"16_CR4","doi-asserted-by":"crossref","unstructured":"Bonamigo RR, Carvalho AV, Sebastiani VR, Silva CM, Pinto AC (2012) HLA and skin cancer. An Bras Dermatol 87:9\u201316; quiz 17\u201318.","DOI":"10.1590\/S0365-05962012000100001"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jid.2016.01.013","volume":"136","author":"MM Asgari","year":"2016","unstructured":"Asgari MM, Wang W, Ioannidis NM, Itnyre J, Hoffmann T, Jorgenson E, Whittemore AS (2016) Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma. J Invest Dermatol 136:930\u2013937","journal-title":"J Invest Dermatol"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.humimm.2017.02.002","volume":"78","author":"P Yesantharao","year":"2017","unstructured":"Yesantharao P, Wang W, Ioannidis NM, Demehri S, Whittemore AS, Asgari MM (2017) Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system. Hum Immunol 78:327\u2013335","journal-title":"Hum Immunol"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0959-8049(05)80143-1","volume":"29A","author":"MT Glover","year":"1993","unstructured":"Glover MT, Bodmer J, Bodmer W, Kennedy LJ, Brown J, Navarrete C, Kwan JT, Leigh IM (1993) HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer. Eur J Cancer 29A:520\u2013524","journal-title":"Eur J Cancer"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/0008-5472.CAN-15-0547","volume":"76","author":"KA Vineretsky","year":"2016","unstructured":"Vineretsky KA, Karagas MR, Christensen BC, Kuriger-Laber JK, Perry AE, Storm CA, Nelson HH (2016) Skin Cancer Risk Is Modified by KIR\/HLA Interactions That Influence the Activation of Natural Killer Immune Cells. Cancer Res 76:370\u2013376","journal-title":"Cancer Res"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069\u20131080","journal-title":"Br J Dermatol"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR, Coldiron BM (2015) Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol 151:1081\u20131086","journal-title":"JAMA Dermatol"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","volume":"146","author":"HW Rogers","year":"2010","unstructured":"Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283\u2013287","journal-title":"Arch Dermatol"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/jid.2012.431","volume":"133","author":"SC Flohil","year":"2013","unstructured":"Flohil SC, Seubring I, van Rossum MM, Coebergh JW, de Vries E, Nijsten T (2013) Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol 133:913\u2013918","journal-title":"J Invest Dermatol"},{"key":"16_CR13","unstructured":"Soyer HP, Rigel D, Wurm EM (2012) Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: JL B, JL J, J S (eds) Dermatology, 3rd ed edn. Elsevier-Saunders, Philadelphia, pp 1773\u20131795."},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.14336\/AD.2017.0503","volume":"8","author":"S Garcovich","year":"2017","unstructured":"Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, Bernabei R, Peris K (2017) Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology. Aging Dis 8:643\u2013661","journal-title":"Aging Dis"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1067\/mjd.2001.114742","volume":"45","author":"RB Harris","year":"2001","unstructured":"Harris RB, Griffith K, Moon TE (2001) Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985\u20131996. J Am Acad Dermatol 45:528\u2013536","journal-title":"J Am Acad Dermatol"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","volume":"49","author":"DL Narayanan","year":"2010","unstructured":"Narayanan DL, Saladi RN, Fox JL (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49:978\u2013986","journal-title":"Int J Dermatol"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/archderm.137.11.1486","volume":"137","author":"H Tsao","year":"2001","unstructured":"Tsao H (2001) Genetics of nonmelanoma skin cancer. Arch Dermatol 137:1486\u20131492","journal-title":"Arch Dermatol"},{"key":"16_CR18","first-page":"43","volume":"58","author":"A Acocella","year":"2009","unstructured":"Acocella A, Sacco R, Bertolai R, Sacco N (2009) Genetic and clinicopathologic aspects of Gorlin-Goltz syndrome (NBCCS): presentation of two case reports and literature review. Minerva Stomatol 58:43\u201353","journal-title":"Minerva Stomatol"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1158\/1078-0432.CCR-09-2570","volume":"16","author":"I Caro","year":"2010","unstructured":"Caro I, Low JA (2010) The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 16:3335\u20133339","journal-title":"Clin Cancer Res"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3892\/mmr.2017.6163","volume":"15","author":"FT Shi","year":"2017","unstructured":"Shi FT, Yu M, Zloty D, Bell RH, Wang E, Akhoundsadegh N, Leung G, Haegert A, Carr N, Shapiro J, McElwee KJ (2017) Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis. Mol Med Rep 15:1441\u20131454","journal-title":"Mol Med Rep"},{"key":"16_CR21","doi-asserted-by":"crossref","unstructured":"Tampa M, Georgescu SR, Mitran CI, Mitran MI, Matei C, Scheau C, Constantin C, Neagu M (2020) Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma. J Clin Med 9.","DOI":"10.3390\/jcm9093010"},{"key":"16_CR22","doi-asserted-by":"crossref","unstructured":"Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutierrez Garcia-Rodrigo C, Fargnoli MC (2017) Understanding the Molecular Genetics of Basal Cell Carcinoma. Int J Mol Sci 18.","DOI":"10.3390\/ijms18112485"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0002-9440(10)63980-6","volume":"158","author":"H Zhang","year":"2001","unstructured":"Zhang H, Ping XL, Lee PK, Wu XL, Yao YJ, Zhang MJ, Silvers DN, Ratner D, Malhotra R, Peacocke M, Tsou HC (2001) Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol 158:381\u2013385","journal-title":"Am J Pathol"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2004.10.003","volume":"225","author":"L Daya-Grosjean","year":"2005","unstructured":"Daya-Grosjean L, Couve-Privat S (2005) Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 225:181\u2013192","journal-title":"Cancer Lett"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdermsci.2015.02.007","volume":"78","author":"A Otsuka","year":"2015","unstructured":"Otsuka A, Levesque MP, Dummer R, Kabashima K (2015) Hedgehog signaling in basal cell carcinoma. J Dermatol Sci 78:95\u2013100","journal-title":"J Dermatol Sci"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","volume":"27","author":"SX Atwood","year":"2015","unstructured":"Atwood SX, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, Ally MS, Kim J, Yao C, Chang AL, Oro AE, Tang JY (2015) Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell 27:342\u2013353","journal-title":"Cancer Cell"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/ncomms5355","volume":"5","author":"C Wang","year":"2014","unstructured":"Wang C, Wu H, Evron T, Vardy E, Han GW, Huang XP, Hufeisen SJ, Mangano TJ, Urban DJ, Katritch V, Cherezov V, Caron MG, Roth BL, Stevens RC (2014) Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat Commun 5:4355","journal-title":"Nat Commun"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1200\/JCO.2014.58.2569","volume":"32","author":"MJ Smith","year":"2014","unstructured":"Smith MJ, Beetz C, Williams SG, Bhaskar SS, O\u2019Sullivan J, Anderson B, Daly SB, Urquhart JE, Bholah Z, Oudit D, Cheesman E, Kelsey A, McCabe MG, Newman WG, Evans DG (2014) Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol 32:4155\u20134161","journal-title":"J Clin Oncol"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/jid.2013.276","volume":"134","author":"SS Jayaraman","year":"2014","unstructured":"Jayaraman SS, Rayhan DJ, Hazany S, Kolodney MS (2014) Mutational landscape of basal cell carcinomas by whole-exome sequencing. J Invest Dermatol 134:213\u2013220","journal-title":"J Invest Dermatol"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2133.2005.06353.x","volume":"152","author":"J Reifenberger","year":"2005","unstructured":"Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G (2005) Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 152:43\u201351","journal-title":"Br J Dermatol"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/1523-1747.ep12874504","volume":"94","author":"JG van der Schroeff","year":"1990","unstructured":"van der Schroeff JG, Evers LM, Boot AJ, Bos JL (1990) Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol 94:423\u2013425","journal-title":"J Invest Dermatol"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ng.2796","volume":"45","author":"DM Levine","year":"2013","unstructured":"Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow WH, Risch HA, Nyren O, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock SJ, Harrington P, Caldas I, Debiram-Beecham I, Caldas C, Hayward NK, Pharoah PD, Fitzgerald RC, Macgregor S, Whiteman DC, Vaughan TL (2013) A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett\u2019s esophagus. Nat Genet 45:1487\u20131493","journal-title":"Nat Genet"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1517\/14728222.11.7.955","volume":"11","author":"HB Koon","year":"2007","unstructured":"Koon HB, Ippolito GC, Banham AH, Tucker PW (2007) FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 11:955\u2013965","journal-title":"Expert Opin Ther Targets"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1210\/me.2014-1171","volume":"28","author":"K Takayama","year":"2014","unstructured":"Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Takahashi S, Homma Y, Urano T, Aburatani H, Inoue S (2014) Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Mol Endocrinol 28:2012\u20132024","journal-title":"Mol Endocrinol"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"12510","DOI":"10.1038\/ncomms12510","volume":"7","author":"HS Chahal","year":"2016","unstructured":"Chahal HS, Wu W, Ransohoff KJ, Yang L, Hedlin H, Desai M, Lin Y, Dai HJ, Qureshi AA, Li WQ, Kraft P, Hinds DA, Tang JY, Han J, Sarin KY (2016) Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma. Nat Commun 7:12510","journal-title":"Nat Commun"},{"key":"16_CR36","doi-asserted-by":"crossref","unstructured":"Martuszewska D, Ljungberg B, Johansson M, Landberg G, Oslakovic C, Dahlback B, Hafizi S (2009) Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer. PLoS One 4:e4350.","DOI":"10.1371\/journal.pone.0004350"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1007\/s13277-016-4927-z","volume":"37","author":"M Sand","year":"2016","unstructured":"Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S (2016) Long-noncoding RNAs in basal cell carcinoma. Tumour Biol 37:10595\u201310608","journal-title":"Tumour Biol"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1091\/mbc.11.1.117","volume":"11","author":"MM Petit","year":"2000","unstructured":"Petit MM, Fradelizi J, Golsteyn RM, Ayoubi TA, Menichi B, Louvard D, Van de Ven WJ, Friederich E (2000) LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity. Mol Biol Cell 11:117\u2013129","journal-title":"Mol Biol Cell"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.136.8.1019","volume":"136","author":"JN Bavinck","year":"2000","unstructured":"Bavinck JN, Bastiaens MT, Marugg ME, Beckers RC, Westendorp RG, Vermeer BJ, Claas FH (2000) Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba. Arch Dermatol 136:1019\u20131022","journal-title":"Arch Dermatol"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00262-009-0701-z","volume":"58","author":"R Mendez","year":"2009","unstructured":"Mendez R, Aptsiauri N, Del Campo A, Maleno I, Cabrera T, Ruiz-Cabello F, Garrido F, Garcia-Lora A (2009) HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank. Cancer Immunol Immunother 58:1507\u20131515","journal-title":"Cancer Immunol Immunother"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s11033-020-06115-w","volume":"48","author":"F Fathi","year":"2021","unstructured":"Fathi F, Zamani B, Piroozmand A, Mozafarpoor S, Seyedhashemi E, ArefNezhad R, Motedayyen H (2021) Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma. Mol Biol Rep 48:2047\u20132052","journal-title":"Mol Biol Rep"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/iji.12447","volume":"46","author":"F Fathi","year":"2019","unstructured":"Fathi F, Ebrahimi M, Eslami A, Hafezi H, Eskandari N, Motedayyen H (2019) Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma. Int J Immunogenet 46:444\u2013450","journal-title":"Int J Immunogenet"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ccell.2016.04.004","volume":"29","author":"GP Dotto","year":"2016","unstructured":"Dotto GP, Rustgi AK (2016) Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. Cancer Cell 29:622\u2013637","journal-title":"Cancer Cell"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","volume":"88","author":"DE Brash","year":"1991","unstructured":"Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 88:10124\u201310128","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1172\/JCI57415","volume":"122","author":"V Ratushny","year":"2012","unstructured":"Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122:464\u2013472","journal-title":"J Clin Invest"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1038\/s41598-017-02831-9","volume":"7","author":"M Fischer","year":"2017","unstructured":"Fischer M, Uxa S, Stanko C, Magin TM, Engeland K (2017) Human papilloma virus E7 oncoprotein abrogates the p53\u2013p21-DREAM pathway. Sci Rep 7:2603","journal-title":"Sci Rep"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1524-4725.2012.02558.x","volume":"39","author":"B Aldabagh","year":"2013","unstructured":"Aldabagh B, Angeles JG, Cardones AR, Arron ST (2013) Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg 39:1\u201323","journal-title":"Dermatol Surg"},{"key":"16_CR48","first-page":"2649","volume":"56","author":"CG Maki","year":"1996","unstructured":"Maki CG, Huibregtse JM, Howley PM (1996) In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 56:2649\u20132654","journal-title":"Cancer Res"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2249.2003.02159.x","volume":"132","author":"AP Black","year":"2003","unstructured":"Black AP, Ogg GS (2003) The role of p53 in the immunobiology of cutaneous squamous cell carcinoma. Clin Exp Immunol 132:379\u2013384","journal-title":"Clin Exp Immunol"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"43418","DOI":"10.1155\/2007\/43418","volume":"2007","author":"A Pacifico","year":"2007","unstructured":"Pacifico A, Leone G (2007) Role of p53 and CDKN2A inactivation in human squamous cell carcinomas. J Biomed Biotechnol 2007:43418","journal-title":"J Biomed Biotechnol"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1365-2133.2003.05230.x","volume":"148","author":"Z Saridaki","year":"2003","unstructured":"Saridaki Z, Liloglou T, Zafiropoulos A, Koumantaki E, Zoras O, Spandidos DA (2003) Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 148:638\u2013648","journal-title":"Br J Dermatol"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR, Wooster R (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91:355\u2013358","journal-title":"Br J Cancer"},{"key":"16_CR53","doi-asserted-by":"crossref","unstructured":"Lazar AD, Dinescu S, Costache M (2020) Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment. J Clin Med 9.","DOI":"10.3390\/jcm9072228"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1105358","volume":"366","author":"F Su","year":"2012","unstructured":"Su F, Viros A, Milagre C, Trunzer K, Bollag G, Spleiss O, Reis-Filho JS, Kong X, Koya RC, Flaherty KT, Chapman PB, Kim MJ, Hayward R, Martin M, Yang H, Wang Q, Hilton H, Hang JS, Noe J, Lambros M, Geyer F, Dhomen N, Niculescu-Duvaz I, Zambon A, Niculescu-Duvaz D, Preece N, Robert L, Otte NJ, Mok S, Kee D, Ma Y, Zhang C, Habets G, Burton EA, Wong B, Nguyen H, Kockx M, Andries L, Lestini B, Nolop KB, Lee RJ, Joe AK, Troy JL, Gonzalez R, Hutson TE, Puzanov I, Chmielowski B, Springer CJ, McArthur GA, Sosman JA, Lo RS, Ribas A, Marais R (2012) RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med 366:207\u2013215","journal-title":"N Engl J Med"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1995-7645(14)60132-2","volume":"7","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Wang GR, Jia JJ, Luo SJ, Wang H, Xiao SX (2014) Expressions of oncogenes c-fos and c-myc in skin lesion of cutaneous squamous cell carcinoma. Asian Pac J Trop Med 7:761\u2013764","journal-title":"Asian Pac J Trop Med"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1365-2133.2009.09351.x","volume":"161","author":"A Toll","year":"2009","unstructured":"Toll A, Salgado R, Yebenes M, Martin-Ezquerra G, Gilaberte M, Baro T, Sole F, Alameda F, Espinet B, Pujol RM (2009) MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol 161:1112\u20131118","journal-title":"Br J Dermatol"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"17761","DOI":"10.1073\/pnas.1114669108","volume":"108","author":"NJ Wang","year":"2011","unstructured":"Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ (2011) Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A 108:17761\u201317766","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41467-020-14594-5","volume":"11","author":"KY Sarin","year":"2020","unstructured":"Sarin KY, Lin Y, Daneshjou R, Ziyatdinov A, Thorleifsson G, Rubin A, Pardo LM, Wu W, Khavari PA, Uitterlinden A, Nijsten T, Toland AE, Olafsson JH, Sigurgeirsson B, Thorisdottir K, Jorgensen E, Whittemore AS, Kraft P, Stacey SN, Stefansson K, Asgari MM, Han J (2020) Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nat Commun 11:820","journal-title":"Nat Commun"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1038\/s41467-018-06149-6","volume":"9","author":"Ioannidis NM, Wang W, Furlotte NA, Hinds DA, andMe Research T, Bustamante CD, Jorgenson E, Asgari MM, Whittemore AS","year":"2018","unstructured":"Ioannidis NM, Wang W, Furlotte NA, Hinds DA, andMe Research T, Bustamante CD, Jorgenson E, Asgari MM, Whittemore AS (2018) Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma. Nat Commun 9:4264","journal-title":"Nat Commun"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1056\/NEJM199109193251203","volume":"325","author":"JN Bouwes Bavinck","year":"1991","unstructured":"Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Schreuder GM, Thorogood J, Persijn GG, Claas FH (1991) Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 325:843\u2013848","journal-title":"N Engl J Med"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.151.3.1579","volume":"151","author":"JN Bavinck","year":"1993","unstructured":"Bavinck JN, Gissmann L, Claas FH, Van der Woude FJ, Persijn GG, Ter Schegget J, Vermeer BJ, Jochmus I, Muller M, Steger G et al (1993) Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol 151:1579\u20131586","journal-title":"J Immunol"},{"key":"16_CR62","first-page":"219","volume":"8","author":"D Garcia-Plata","year":"1993","unstructured":"Garcia-Plata D, Mozos E, Carrasco L, Solana R (1993) HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations. Histol Histopathol 8:219\u2013226","journal-title":"Histol Histopathol"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-4362.1985.tb05719.x","volume":"24","author":"LA Hua","year":"1985","unstructured":"Hua LA, Kagen CN, Carpenter RJ, Goltz RW (1985) HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin. Int J Dermatol 24:660\u2013663","journal-title":"Int J Dermatol"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-0560.1990.tb00058.x","volume":"17","author":"AC Markey","year":"1990","unstructured":"Markey AC, Churchill LJ, MacDonald DM (1990) Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours. J Cutan Pathol 17:65\u201371","journal-title":"J Cutan Pathol"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bjd.17917","volume":"181","author":"MR Roberts","year":"2019","unstructured":"Roberts MR, Asgari MM, Toland AE (2019) Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Br J Dermatol 181:1146\u20131155","journal-title":"Br J Dermatol"}],"container-title":["Advances in Experimental Medicine and Biology","The Immunogenetics of Dermatologic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-92616-8_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:54:17Z","timestamp":1674953657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-92616-8_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030926151","9783030926168"],"references-count":65,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-92616-8_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}